Source: Islamic Republic News Agency

Iranian researchers at Royan Institute are conducting clinical trials to treat chronic and acute kidney disease by using mesenchymal stem cells, an official said.

Royan Institute

Speaking on the sidelines of the 12th Asian Congress of Urology (ACU), Dr. Reza Moqaddas-Ali, the head of Kidney Group of Stem Cells Research Center affiliated to Royan Institute, added that the researchers have conducted animal trials successfully.

"Results of animal trials showed that mesenchymal stem cell treatment has been found to be a good treatment for acute kidney injury," he said.

"The treatment was not very effective in treating chronic kidney disease, but helps prevent progression of acute kidney injury to advanced chronic kidney disease."

Chronic kidney disease, also known as chronic renal disease, is a progressive loss in renal function over a period of months or years.

Acute kidney injury (AKI) is an abrupt loss of kidney function that develops within seven days.

Kidney Diseases

The ACU took place on Kish Island in southern Iran from December 5 to 9.

Read the original:
Royan using stem cells to treat kidney diseases